- Home
- LTBR vs TERN Comparison
LTBR vs TERN Comparison
Compare LTBR & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- TERN
- Stock Information
- Founded
- LTBR 1992
- TERN 2017
- Country
- LTBR United States
- TERN United States
- Employees
- LTBR N/A
- TERN N/A
- Industry
- LTBR Professional Services
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- TERN Health Care
- Exchange
- LTBR Nasdaq
- TERN Nasdaq
- Market Cap
- LTBR 326.6M
- TERN 321.4M
- IPO Year
- LTBR N/A
- TERN 2021
- Fundamental
- Price
- LTBR $12.72
- TERN $4.45
- Analyst Decision
- LTBR
- TERN Buy
- Analyst Count
- LTBR 0
- TERN 5
- Target Price
- LTBR N/A
- TERN $15.63
- AVG Volume (30 Days)
- LTBR 1.8M
- TERN 902.6K
- Earning Date
- LTBR 07-30-2025
- TERN 08-04-2025
- Dividend Yield
- LTBR N/A
- TERN N/A
- EPS Growth
- LTBR N/A
- TERN N/A
- EPS
- LTBR N/A
- TERN N/A
- Revenue
- LTBR N/A
- TERN N/A
- Revenue This Year
- LTBR N/A
- TERN N/A
- Revenue Next Year
- LTBR N/A
- TERN N/A
- P/E Ratio
- LTBR N/A
- TERN N/A
- Revenue Growth
- LTBR N/A
- TERN N/A
- 52 Week Low
- LTBR $2.24
- TERN $1.87
- 52 Week High
- LTBR $17.70
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- LTBR 45.58
- TERN 65.96
- Support Level
- LTBR $12.33
- TERN $3.67
- Resistance Level
- LTBR $14.10
- TERN $4.39
- Average True Range (ATR)
- LTBR 0.90
- TERN 0.31
- MACD
- LTBR -0.27
- TERN 0.01
- Stochastic Oscillator
- LTBR 15.56
- TERN 91.67
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.